Van den Eijnden-van Raaij et al., 1988 - Google Patents
A new method for high yield purification of type beta transforming growth factor from human plateletsVan den Eijnden-van Raaij et al., 1988
- Document ID
- 7323082226027800220
- Author
- Van den Eijnden-van Raaij A
- Koornneef I
- Van Zoelen E
- Publication year
- Publication venue
- Biochemical and biophysical research communications
External Links
Snippet
A new method was developed for the purification of type beta transforming growth factor from human platelets. This method is a three-step procedure including gel filtration, weak cation exchange HPLC and reverse phase HPLC. All steps are carried out at low pH using …
- 210000001772 Blood Platelets 0 title abstract description 40
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
- C07K14/4703—Inhibitors; Suppressors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/495—Transforming growth factor [TGF]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors; against growth regulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/74—Inducing cell proliferation
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Van den Eijnden-van Raaij et al. | A new method for high yield purification of type beta transforming growth factor from human platelets | |
Wakefield et al. | Latent transforming growth factor-beta from human platelets. A high molecular weight complex containing precursor sequences. | |
US4785079A (en) | Isolation of fibroblast growth factor | |
Zwiebel et al. | Partial purification of transforming growth factors from human milk | |
EP0218868A2 (en) | Preparation of pure human tumor necrosis factor and hybridomas producing monoclonal antibodies to human tumor necrosis factor | |
Pouysségur et al. | Isolation and immunological characterization of a glucose-regulated fibroblast cell surface glycoprotein and its nonglycosylated precursor | |
EP0684260A2 (en) | Tissue-derived tumor growth inhibitors, methods of preparation and uses thereof | |
US4882275A (en) | Method of purifying endothelial cell growth factors using immobilized heparin | |
Brigstock | Purification and Characterization of Connective Tissue Growth Factor Using Heparin Affinity Chromatography | |
US5523290A (en) | Antiproliferation factor | |
Roberts et al. | Isolation and characterization of TGF-β2 and TGF-β5 from medium conditioned by Xenopus XTC cells | |
Assoian | [14] Purification of type-β transforming growth factor from human platelet | |
EP0629238B1 (en) | Autotaxin: motility stimulating protein useful in cancer diagnosis and therapy | |
Presta et al. | High molecular weight immunoreactive basic fibroblast growth factor-like proteins in rat pituitary and brain | |
Furuya et al. | Paracrine growth stimulation of androgen-responsive Shionogi carcinoma 115 by its autonomous subline (Chiba subline 2) | |
EP0132021B1 (en) | Tgf polypeptides, antigenic oligopeptides derived therefrom and antibodies produced therefrom | |
Van den Eijnden-Van Raaij et al. | Purification of a growth factor related to platelet-derived growth factor and a type β transforming growth factor secreted by mouse neuroblastoma cells. A general strategy for the purification of basic polypeptide growth factors | |
US5644026A (en) | Epitaxin, a cell motility factor | |
Laursen et al. | Purification and characterization of an α1-antichymotrypsin-like 66 kDa protein from the human breast cancer cell line, MCF-7 | |
EP0241830A2 (en) | Hepatoma-derived growth factor | |
US5071956A (en) | Protein with vascular activity derived from monocytes and its analogues, a process for its extraction and their uses for therapeutic purposes and for the preparation of antibodies | |
Ranganathan et al. | Transforming growth factor type β in normal human urine | |
Wei et al. | Soluble multimer of recombinant endostatin expressed in E. coli has anti-angiogenesis activity | |
AU668072B2 (en) | Tissue-derived tumor growth inhibitors, methods of preparation and uses thereof | |
Pepinsky et al. | Detection of VAC‐β (annexin‐8) in human placenta |